<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="5" ids="47916">Flavonoids</z:chebi> are an important group of recognized <z:chebi fb="11" ids="22586">antioxidants</z:chebi> ubiquitous in fruits, vegetables and herbs </plain></SENT>
<SENT sid="1" pm="."><plain>There are epidemiological evidences for the <z:hpo ids='HP_0001297'>stroke</z:hpo>-protecting capacity of <z:chebi fb="5" ids="47916">flavonoids</z:chebi> and while the neuroprotective power of complex extracts rich in <z:chebi fb="5" ids="47916">flavonoids</z:chebi> like those of Ginkgo biloba, green tea or lyophilized red wine have been demonstrated in several studies, neuroprotection by individual <z:chebi fb="5" ids="47916">flavonoids</z:chebi> has been poorly studied in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>The neuroprotective capacity of individual <z:chebi fb="5" ids="47916">flavonoids</z:chebi> was studied in PC12 cells in culture and in a model of permanent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (permanent Middle Cerebral <z:mp ids='MP_0006134'>Artery Occlusion</z:mp> - pMCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>In the in vivo experiments, <z:chebi fb="5" ids="47916">flavonoids</z:chebi> were administered in lecithin preparations to facilitate the crossing of the blood brain barrier </plain></SENT>
<SENT sid="4" pm="."><plain>The simultaneous incubation of PC12 cells with 200 micro M <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> (<z:chebi fb="0" ids="30492">H2O2</z:chebi>) and different <z:chebi fb="5" ids="47916">flavonoids</z:chebi> for 30 min resulted in a conspicuous profile: <z:chebi fb="0" ids="16243">quercetin</z:chebi>, <z:chebi fb="0" ids="42567">fisetin</z:chebi>, <z:chebi fb="0" ids="15864">luteolin</z:chebi> and <z:chebi fb="0" ids="18152">myricetin</z:chebi> significantly increased cell survival while <z:chebi fb="0" ids="23053">catechin</z:chebi>, kaempherol and <z:chebi fb="0" ids="38747">taxifolin</z:chebi> did not </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="16243">Quercetin</z:chebi> was detected in brain tissue 30 min and 1 h after intraperitoneal administration </plain></SENT>
<SENT sid="6" pm="."><plain>When one of the protective <z:chebi fb="5" ids="47916">flavonoids</z:chebi> (<z:chebi fb="0" ids="16243">quercetin</z:chebi>) and one of those that failed to increase PC12 cell survival (<z:chebi fb="0" ids="23053">catechin</z:chebi>) were assessed for their protective capacity in the pMCAO model, administered i.p </plain></SENT>
<SENT sid="7" pm="."><plain>30 min after vessel occlusion, <z:chebi fb="0" ids="16243">quercetin</z:chebi> significantly decreased the brain ischemic lesion while <z:chebi fb="0" ids="23053">catechin</z:chebi> did not </plain></SENT>
<SENT sid="8" pm="."><plain>It is concluded that when administered in liposomal preparations, <z:chebi fb="5" ids="47916">flavonoids</z:chebi> structurally related to <z:chebi fb="0" ids="16243">quercetin</z:chebi> could become leads for the development of a new generation of molecules to be clinically effective in human <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>